Wednesday, July 8, 2026

biotech · Recurrent Plasma Cell Myeloma · Anal Cancer Metastatic · ONCY

Oncolytics Biotech

Oncolytics Biotech clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

4350 Executive Dr, 325, San Diego, California 92121, US HQ
1998 Founded
46 Employees
Public company Type
ONCY · NYSE Ticker
Company details
Status
Public
HQ
4350 Executive Dr, 325, San Diego, California 92121, US
Founded
1998
Employees
46
Programs
23
Drugs
14
Patents
66
Intelligence · Clinical Programs

Oncolytics Biotech projects

14 ClinicalTrials.gov programs sponsored by Oncolytics Biotech.

Oncolytics Biotech has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Bevacizumab

    ONCOLYTICS BIOTECH INC

    Ras-mutated Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial
  2. Docetaxel, Reolysin and Prednisone

    ONCOLYTICS BIOTECH INC

    Prostate Cancer

    phase 2 small molecule completed

    1 trial
  3. Folfox plus Bevacizumab and reolysin

    ONCOLYTICS BIOTECH INC

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial
  4. Paclitaxel

    ONCOLYTICS BIOTECH INC

    Breast Cancer Metastatic

    phase 2 small molecule active

    1 trial
  5. Paclitaxel

    ONCOLYTICS BIOTECH INC

    Metastatic Breast Cancer

    phase 2 small molecule completed

    1 trial
  6. Pelareorep

    ONCOLYTICS BIOTECH INC

    Anal Cancer Metastatic

    phase 2 small molecule active

    1 trial
  7. Pelareorep

    ONCOLYTICS BIOTECH INC

    Anatomic Stage IV Breast Cancer AJCC v8

    phase 2 mab active

    1 trial
  8. Pemetrexed and Reolysin (and safety run-in)

    ONCOLYTICS BIOTECH INC

    Non Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial
  9. REO 029

    ONCOLYTICS BIOTECH INC

    Patients with advanced or metastatic gastrointestinal (GI) tumors.

    phase 2 small molecule active

    1 trial
  10. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Melanoma

    phase 2 mab completed

    1 trial
  11. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic or Recurrent Squamous Cell Carcinoma of the Lung

    phase 2 mab completed

    1 trial
  12. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Pancreatic Adenocarcinoma

    phase 2 mab completed

    1 trial
  13. REOLYSIN®

    ONCOLYTICS BIOTECH INC

    Carcinoma, Non-small Cell Lung

    phase 2 mab completed

    1 trial
  14. REOLYSIN®

    ONCOLYTICS BIOTECH INC

    Osteosarcoma

    phase 2 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Oncolytics Biotech have?

14 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.